Skip to Main Content

Paper Details

Genome-wide DNA methylation measurements in prostate tissues uncovers novel prostate cancer diagnostic biomarkers and transcription factor binding patterns.
BMC Cancer
40
2017
Cancer, HumanMethylation450, benign, binding sites, blood plasma, differentially methylated regions, differentially methylated sites, enhancer of zeste homolog 2, gene regulatory regions, genome, malignant, malignant prostate, malignant prostate tissues, methylation patterns, patient, prostate cancer, prostate cancers
Author NameAffiliation
Brittany N LasseigneHudsonAlpha Institute for Biotechnology
Devin AbsherHudsonAlpha Institute for Biotechnology
Devin AbsherHudsonAlpha Institute for Biotechnology
Sara J CooperHudsonAlpha Institute for Biotechnology
Richard M MyersHudsonAlpha Institute for Biotechnology
Richard M MyersHudsonAlpha Institute for Biotechnology
  • 1 - 6

Datasets

Release 1.2